Aisling Capital Management LP
An institutional investment manager in NEW YORK, NY. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 13, 2026. SEC CIK 1766721.
- Reported value$471.6m
- Positions14
Holdings: 14 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Bridgebio Pharma IncBBIO | COM | 10806X102 | 342 | 72.5% | 4,589,611 | Reduced−500,000 | |
| Monte Rosa Therapeutics IncGLUE | COM | 61225M102 | 37.6 | 8.0% | 1,555,664 | Unchanged | |
| Syndax Pharmaceuticals IncSNDX | COM | 87164F105 | 28.8 | 6.1% | 1,316,806 | Unchanged | |
| Compass Pathways plcCMPS | SPONSORED ADS | 20451W101 | 20.3 | 4.3% | 1,432,336 | Unchanged | |
| Bicara Therapeutics IncBCAX | COM | 055477103 | 16.9 | 3.6% | 568,919 | Unchanged | |
| Bridgebio Oncology TherapeutBBOT | COM NEW | 107924102 | 7.8 | 1.6% | 1,018,018 | Unchanged | |
| Scholar Rock HLDG CorpSRRK | COM | 80706P103 | 4.2 | 0.9% | 77,031 | Unchanged | |
| Urogen Pharma Ltd | COM | M96088105 | 4.0 | 0.8% | 108,000 | Unchanged | |
| Biomea Fusion IncBMEA | COM | 09077A106 | 3.0 | 0.6% | 2,048,757 | Unchanged | |
| Aclaris Therapeutics IncACRS | COM | 00461U105 | 2.3 | 0.5% | 434,455 | Unchanged | |
| Eupraxia Pharmaceuticals IncEPRX | COM | 29842P105 | 2.1 | 0.5% | 325,000 | Unchanged | |
| VTV Therapeutics IncVTVT | CL A NEW | 918385204 | 1.9 | 0.4% | 50,000 | New+50,000 | |
| Marker Therapeutics IncMRKR | COM NEW | 57055L206 | 0.5 | 0.1% | 325,370 | Unchanged | |
| Onkure Therapeutics IncOKUR | COM CL A | 68277Q105 | 0.4 | <0.1% | 88,607 | Unchanged |
Source: SEC EDGAR, Form 13F-HR, accession 0001766721-26-000003 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.